Tag: Continuous Glucose Monitoring System

PARSIPPANY, N.J. – Ascensia Diabetes Care has launched the next-generation Eversense E3 Continuous Glucose Monitoring System for patients in the U.S., alongside the new Eversense PASS savings program. Eversense E3, which is developed be Senseonics Holdings, was approved for use up to six months by the U.S. Food and Drug Administration earlier this year, making it the longest lasting CGM sensor available in the country. “We are thrilled to offer Eversense E3 to people with diabetes in...

WASHINGTON - Medicare beneficiaries using Dexcom's G5 Mobile continuous glucose monitoring system cannot use smartphone apps or tablets to display glucose data if they want to have the CGM device reimbursed, according to recently released guidance from CMS. If a beneficiary uses a non-DME device (smart phone, tablet, etc.) as the display device, either separately or in combination with the CGM receiver classified as DME, the supply allowance is non-covered. CMS in January said it would classify...